+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?
Published . Updated .
This report is about AI and big tech and pharma and health.
Directly affected
- No company is named in this report.
Indirectly affected
- QQQ Invesco QQQ-2.6% 30d
Invesco QQQ: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story.
- AIQ Global X Artificial Intelligence & Technology ETF-0.9% 19d
Global X Artificial Intelligence & Technology ETF: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
- MSFT Microsoft+4.0% 30d
Microsoft (prepackaged software): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story.
- GOOGL Alphabet-21.2% 30d
Alphabet (computer programming, data processing, etc.): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story.
- PFE Pfizer+8.9% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| QQQ | +3.12% | +5.08% | base | after close | after close | after close | after close |
| AIQ | +4.74% | +7.15% | base | after close | after close | after close | after close |
| XLV | -3.03% | -2.77% | base | after close | after close | after close | after close |
| LLY | -9.71% | -8.92% | base | after close | after close | after close | after close |
| JNJ | -2.53% | -0.72% | base | after close | after close | after close | after close |
| MSFT | +2.03% | +1.97% | base | after close | after close | after close | after close |
| GOOGL | +13.19% | +16.25% | base | after close | after close | after close | after close |
| PFE | -2.33% | -3.34% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat? Investing.com
Source: Investing.com
The price since 2 Nov 2026: Invesco Qqq Trust, Series 1 (QQQ) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| Global X Fds (AIQ) | three days earlier | +7.15% | final price |
| Global X Fds (AIQ) | five days earlier | +4.74% | final price |
| Alphabet (GOOGL) | three days earlier | +16.25% | final price |
| Alphabet (GOOGL) | five days earlier | +13.19% | final price |
| Johnson & Johnson (JNJ) | three days earlier | -0.72% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -2.53% | final price |
| Eli Lilly (LLY) | three days earlier | -8.92% | final price |
| Eli Lilly (LLY) | five days earlier | -9.71% | final price |
| Microsoft (MSFT) | three days earlier | +1.97% | final price |
| Microsoft (MSFT) | five days earlier | +2.03% | final price |
| Pfizer (PFE) | three days earlier | -3.34% | final price |
| Pfizer (PFE) | five days earlier | -2.33% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | three days earlier | +5.08% | final price |
| Invesco Qqq Trust, Series 1 (QQQ) | five days earlier | +3.12% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -2.77% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.03% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold Microsoft (MSFT) (held by a spouse), worth $250,001 - $500,000 on 2 Oct 2026. That is 31 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Lisa McClain bought Microsoft (MSFT) (held by a spouse), worth $1,001 - $15,000 on 30 Sep 2026. That is 33 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Michael Rulli sold Microsoft (MSFT), worth $1,001 - $15,000 on 28 Sep 2026. That is 35 days before publication. Filed 2 Oct 2026. View the filing.
- Rep. Pete Sessions sold Alphabet (GOOGL), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Alphabet (GOOGL) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Alphabet (GOOGL), worth $1,001 - $15,000 on 27 Aug 2026. That is 67 days before publication. Filed 12 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 73 days before publication. Filed 8 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Invesco Qqq Trust, Series 1 (QQQ)
Companies carried with this story
- QQQ Invesco Qqq Trust, Series 1
In “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” Invesco Qqq Trust, Series 1 (QQQ) is linked, with no stored direction, medium confidence. Reason on file: Invesco QQQ: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story
- AIQ Global X Fds
In “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” Global X Fds (AIQ) is linked, with no stored direction, medium confidence. Reason on file: Global X Artificial Intelligence & Technology ETF: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story
- XLV Select Sector Spdr Tr
For “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “pharma” (pharma and health) in this story
- LLY Eli Lilly
For “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” Eli Lilly (LLY) is linked, with no stored direction, medium confidence. Reason on file: Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- JNJ Johnson & Johnson
In “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence. Reason on file: Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
- MSFT Microsoft
Microsoft (MSFT) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?.” Reason on file: Microsoft (prepackaged software): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story
- GOOGL Alphabet
In “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” Alphabet (GOOGL) is linked, with no stored direction, medium confidence. Reason on file: Alphabet (computer programming, data processing, etc.): big tech's AI spending and demand drive its shares. Linked by “ai” (AI and big tech) in this story
- PFE Pfizer
In “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” Pfizer (PFE) is linked, with no stored direction, medium confidence. Reason on file: Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “pharma” (pharma and health) in this story
Invesco Qqq Trust, Series 1 (QQQ)
Invesco Qqq Trust, Series 1 (QQQ) is the company in “+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?,” the 2 Nov 2026 this story story.
Invesco Qqq Trust, Series 1 (QQQ) is on the page because Invesco QQQ: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story
A second company, Global X Fds (AIQ), is listed for a different reason: Global X Artificial Intelligence & Technology ETF: it holds the big tech and AI names. Linked by “ai” (AI and big tech) in this story
Price levels for Invesco Qqq Trust, Series 1 (QQQ)
AIQ traded between 61.70 and 67.40 across 14 sessions. The latest close on file is 62.94. QQQ traded between 683.47 and 762.84 across 20 sessions. The latest close on file is 690.51.
A simple score for Invesco Qqq Trust, Series 1 (QQQ)
46 out of 100
“+66% since picked: Which pharma stock did our AI pick before a 30% earnings beat?” scores 46 out of 100. The score uses 1 sources, and 8 linked companies.